<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore the effect of delta-opioid receptor (DOR) in electroacupuncture (EA) protecting the brain against <z:hpo ids='HP_0011009'>acute</z:hpo> ischemic injury </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Fifty-one rats were randomly divided into sham <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group, sham EA group, EA group, and EA+DOR <z:chebi fb="68" ids="48706">antagonist</z:chebi> (naltrindole) group </plain></SENT>
<SENT sid="2" pm="."><plain>Transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (1 hour) was induced in rat brain by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) method </plain></SENT>
<SENT sid="3" pm="."><plain>EA was applied on Shuigou (GV 26) and Neiguan (PC 6) for 30 min, starting immediately after the <z:hpo ids='HP_0003674'>onset</z:hpo> of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>Neurological deficit scores and volume of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> were detected after 24-hour reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>Other 12 rats were randomly divided into sham <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group, EA group and EA + naltrindole group </plain></SENT>
<SENT sid="6" pm="."><plain>DOR protein expressions were assessed by Western blotting after 24-hour reperfusion </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: In comparison with the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group and sham EA group, EA significantly reduced ischemic infarction and neurological deficits (P&lt;0.05); EA significantly increased the expression of 60 kD DOR protein (P&lt;0.05) and tended to increase that of 36 kD DOR protein (P&gt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>When naltrindole was combined with EA, the naltrindole completely abolished the EA-induced protection in ischemic infarction and neurological deficits, and also arrested the expression of DOR </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: EA can up-regulate DOR expression and protect the brain from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury </plain></SENT>
</text></document>